Biotech firms are engineering smarter, safer gene delivery systems to enhance the safety and efficacy of genetic medicines.

Additionally, improving CAR-T biological efficiency could reduce dosing needs, further cutting costs and expanding access.

“Our CB-SCs can target different compartments of the immune system, educating and correcting their dysfunctions at a fundamental level,” says Dr. Zhao. “This therapy has the potential to revolutionize ...

CellVoyant leverages AI and live-cell imaging to predict cellular behavior, transforming cell therapy development and making ...

Both studies, which are reporting the results of early-stage clinical trials, show that the interventions were safe, and that ...

University of Galway’s Dr Ruth Levey is advancing the field of cell therapy delivery to treat chronic diseases.

AAP FactCheck - The co-author of a study being cited with claims that fasting can remove all cancer and Alzheimer's cells ...

The cell therapy was developed at MSK in the laboratories ... early forms of dopamine-producing neurons. They scaled up the process to produce large batches of these cells. The resulting product ...

When even one tiny section of a person’s genetic code becomes mutated or modified, cells can begin to act out of ...